Etiotropic therapy: possibilities and limitations
To date, medicine lacks a wide range of specific agents for the direct targeting of ARVI pathogens. The development of RNA "uncoating" inhibitors and cell receptor blockers remains at the research stage.
Clinical practice utilizes nonspecific methods:
- Intranasal $\alpha$-interferon to stimulate the local immune response.
- Oxoline ointment or drops, which inactivate extracellular forms of adeno-, rhino-, and myxoviruses.
Pathogenetic and symptomatic treatment
This is a key stage of therapy aimed at relieving the patient's condition and supporting the body's defense mechanisms:
- Detoxification: ample warm fluids to eliminate viral metabolic products.
- Antipyretics: fever control when necessary.
- Vitamin therapy: use of vitamin C for general bodily support.
- Desensitizing therapy: to reduce the severity of inflammatory reactions.
When to prescribe antibiotics?
It is important to remember: antibacterial drugs do not work against viruses. Their prescription is justified in only one case — when a secondary bacterial infection develops. Unjustified use of antibiotics in an uncomplicated course of ARVI is unacceptable.
Briefly: answers to topical questions
Which specific drugs belong to viral RNA "uncoating" inhibitors?
Viral RNA "uncoating" inhibitors include M2 channel blockers, also known as adamantanes. The only specific drug from this group mentioned in the sources is rimantadine.
- Rimantadine — disrupts viral uncoating (inhibits virus release from the endosome), specific for influenza A virus.
The drug is classified as an agent with proven antiviral efficacy, though high resistance to it is currently observed.
Which antipyretics are the drugs of choice in uncomplicated ARVI?
The drugs of choice (first-line agents) for managing febrile fever in respiratory infections are ibuprofen and paracetamol.
- Ibuprofen — used as an antipyretic for febrile fever.
- Paracetamol (acetaminophen) — an effective antipyretic, which is also the safest drug during pregnancy.
Drugs are prescribed strictly "as needed" when the temperature threshold is reached; routine scheduled administration is not recommended. The use of other nonsteroidal anti-inflammatory drugs is permitted exclusively for strict individual indications.
Which bacterial complications most commonly require antibiotic prescription in ARVI?
Antibacterial therapy in ARVI is required upon the development of complications caused by secondary bacterial flora. Such complications include:
- Bacterial bronchitis.
- Pneumonia.
- Otitis — inflammation of the ear accompanied by constant, throbbing, or shooting pain.
- Sinusitis — inflammation of the paranasal sinuses, such as maxillary sinusitis or frontal sinusitis.
Antibacterial therapy is recommended in cases of suspected concomitant bacterial infection, failure of pathogenetic, symptomatic, and antiviral therapy, as well as for moderate-to-severe ARVI complications caused by superimposed bacterial flora.
Which drug classes are considered nonspecific antiviral agents in ARVI?
Nonspecific antiviral agents in the treatment of ARVI include:
- $\alpha$-interferon — administered intranasally.
- Oxoline — used as an ointment or drops intranasally and inactivates extracellular forms of adeno-, rhino-, and myxoviruses.
"P-D-F-V-D": Fluids, Detoxification, Antipyretics, Vitamins, Desensitization.
Class and exam questions
Why are antibiotics not prescribed immediately for ARVI?
Antibiotics act solely on bacteria. They are useless in viral infections and are prescribed exclusively upon the development of secondary bacterial complications.
What is the mechanism of action of oxoline ointment?
It inactivates extracellular forms of viruses (adeno-, rhino-, and myxoviruses) when applied to the nasal mucosa.
What forms the basis of ARVI treatment?
The foundation consists of pathogenetic and symptomatic therapy aimed at detoxification, fever reduction, and bodily support.
What else to study on this topic
- Mechanisms of action of viral RNA "uncoating" inhibitors.
- Comparative efficacy of various $\alpha$-interferon formulations.
- Diagnostic criteria for secondary bacterial infection.
- The role of desensitizing agents in relieving mucosal edema.
- Prospects for the development of cell receptor blockers.
Study the full topic in the «Microbiology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "ARVI Treatment" and 4,383 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 141 video lectures on the subject
Other topics in the section "ARVI pathogens"
Free video lessons: microbiologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.